Delaware
|
| |
6770
|
| |
86-2433757
|
(State or other Jurisdiction of
Incorporation Or Organization)
|
| |
(Primary Standard Industrial
Classification Code Number)
|
| |
(I.R.S. Employer
Identification Number)
|
Christian O. Nagler, Esq.
Peter S. Seligson, Esq.
Kirkland & Ellis LLP
601 Lexington Avenue
New York, New York 10022
Tel: (212) 446-4800
Fax: (212) 446-4900
|
| |
Michael P. Heinz, Esq.
William J. Cooper, Esq.
Sidley Austin LLP
787 Seventh Avenue
New York, New York 10019
Tel: (212) 839-5300
Fax: (212) 839-5599
|
Large accelerated filer
|
| |
☐
|
| |
Accelerated filer
|
| |
☐
|
Non-accelerated filer
|
| |
☒
|
| |
Smaller reporting company
|
| |
☒
|
|
| |
|
| |
Emerging growth company
|
| |
☒
|
Title of Each Class of Securities to be Registered
|
| |
Amount Being
Registered
|
| |
Proposed Maximum
Offering Price
Per Security(1)
|
| |
Proposed Maximum
Aggregate
Offering Price(1)
|
| |
Amount of
Registration Fee
|
Units, each consisting of one share of Class A common stock, $0.0001 par value per share, and one-half of one warrant(2)
|
| |
28,750,000 Units
|
| |
$10.00
|
| |
$287,500,000
|
| |
$31,366.25
|
Shares of Class A common stock included as part of the units(3)
|
| |
28,750,000 Shares
|
| |
—
|
| |
—
|
| |
—(4)
|
Redeemable warrants included as part of the units(3)
|
| |
14,375,000 Warrants
|
| |
—
|
| |
—
|
| |
—(4)
|
Total
|
| |
|
| |
|
| |
$287,500,000
|
| |
$31,366.25
|
(1)
|
Estimated solely for the purpose of calculating the registration fee.
|
(2)
|
Includes 3,750,000 units, consisting of 3,750,000 shares of Class A common stock and 1,875,000 warrants, which may be issued upon exercise of a 45-day option granted to the underwriters to cover over-allotments, if any.
|
(3)
|
Pursuant to Rule 416(a), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
|
(4)
|
No fee pursuant to Rule 457(g).
|
|
| |
Per Unit
|
| |
Total
|
Public offering price
|
| |
$10.00
|
| |
$250,000,000
|
Underwriting discounts and commissions(1)
|
| |
$0.55
|
| |
$13,750,000
|
Proceeds, before expenses, to Focus Impact Acquisition Corp.
|
| |
$9.45
|
| |
$236,250,000
|
(1)
|
Includes $0.35 per unit, or $8,750,000 (or up to $10,062,500 if the underwriters’ over-allotment option is exercised in full) in the aggregate payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States as described herein. The deferred commissions will be released to the underwriters only on completion of an initial business combination, as described in this prospectus. See the section of this prospectus entitled “Underwriting.”
|
Citigroup
|
| |
Goldman Sachs & Co. LLC
|
CastleOak Securities, L.P.
|
| |
Siebert Williams Shank
|
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
•
|
“common stock” are to our Class A common stock and our Class B common stock, collectively;
|
•
|
“founder shares” are to shares of our Class B common stock initially purchased by our sponsor in a private placement prior to this offering, and the shares of our Class A common stock issued upon the conversion thereof as provided herein; and
|
•
|
“initial stockholders” are to holders of our founder shares prior to this offering;
|
•
|
“management” or our “management team” are to our officers and directors, and “directors” are to our current directors and director nominees;
|
•
|
“private placement warrants” are to the warrants issued to our sponsor in a private placement simultaneously with the closing of this offering.
|
•
|
“public shares” are to shares of our Class A common stock sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market);
|
•
|
“public stockholders” are to the holders of our public shares, including our initial stockholders and management team to the extent our initial stockholders and/or members of our management team purchase public shares, provided that each initial stockholder’s and member of our management team’s status as a “public stockholder” shall only exist with respect to such public shares;
|
•
|
“sponsor” are to Focus Impact Sponsor, LLC, a Delaware limited liability company;
|
•
|
“we,” “us,” “our,” “company” or “our company” are to Focus Impact Acquisition Corp.;
|
•
|
Sourcing, structuring, acquiring, integrating and selling businesses in and adjacent to our target sectors;
|
•
|
Operating sophisticated business and non-profit organizations and executing complex transactions;
|
•
|
Identifying, recruiting and developing promising talent;
|
•
|
Accessing the capital markets and marketing organizations; and,
|
•
|
Advising companies and boards on diverse corporate matters, including but not limited to the integration of socially positive concerns into business operations for value creation.
|
•
|
Passion to fulfill our mission to develop as a successful public company using our Social-Forward criteria.
|
•
|
Compelling sourcing opportunities and strategic relationships, including our highly differentiated sourcing engine provided via our relationship with secondaries investment firm Auldbrass Partners, as well as the collective networks of our officers, directors, and advisory board members.
|
•
|
Extensive influence and reach through a broad network that spans a range of leaders in business, entertainment, government and philanthropy.
|
•
|
Successful track record of investing, transaction and capital markets experience that demonstrates a strong ability to source, select and execute.
|
•
|
Deep insights into and subject matter expertise in a target-rich universe that provides a large total addressable market.
|
•
|
Values-based leadership attractive to target businesses and with the ability to amplify and validate the efforts of a Social-Forward Company.
|
•
|
Either demonstrate or appreciate the value of supporting health and well-being, quality education, reducing economic inequality and promoting decent work in the United States.
|
•
|
Are motivated to fulfill our mission and be positioned as, or further developed as, a Social-Forward Company.
|
•
|
Are excited about working with our company to realize in parallel both shareholder and social value.
|
•
|
Are positioned to materially benefit from our officers’ and directors’ knowledge of the target industry and relationships.
|
•
|
Have strong management teams with a clear vision to either maintaining or, if an early-stage business, creating sustainable cash flows.
|
•
|
Are positioned to benefit from access to public capital markets and the merits of being a Social-Forward Company.
|
•
|
one share of Class A common stock; and
|
•
|
one-half of one warrant.
|
(1)
|
Assumes no exercise of the underwriter’s over-allotment option and the forfeiture by our sponsor of 937,500 founder shares.
|
(2)
|
Includes up to 937,500 founder shares that are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised.
|
(3)
|
The shares of common stock included in the units are 25,000,000 shares of Class A common stock. The remaining 6,250,000 are founder shares and are classified as shares of Class B common stock, which shares are convertible into shares of our Class A common stock on a one-for-one basis, subject to adjustment as described below adjacent to the caption “Founder shares conversion and anti-dilution rights.
|
•
|
30 days after the completion of our initial business combination; and
|
•
|
twelve months from the closing of this offering;
|
•
|
in whole and not in part;
|
•
|
at a price of $0.01 per warrant;
|
•
|
upon a minimum of 30 days’ prior written notice of redemption, which we refer to as the “30-day redemption period”; and
|
•
|
if, and only if, the last reported sale price (the “closing price”) of our Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Stockholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day
|
•
|
in whole and not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Stockholders’ Warrants” based on the redemption date and the “fair market value” of our Class A common stock (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Stockholders’ Warrants”;
|
•
|
if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Stockholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders; and
|
•
|
if the closing price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Stockholders’ Warrants — Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
|
•
|
the founder shares are shares of Class B common stock that automatically convert into shares of our Class A common stock at the time of our initial business combination, or at any time prior thereto at the option of the holder, on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein;
|
•
|
prior to our initial business combination only holders of the founder shares have the right to vote on the election of directors and holders of a majority of our founder shares may remove a member of the board of directors for any reason;
|
•
|
the founder shares are subject to certain transfer restrictions, as described in more detail below;
|
•
|
our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed (i) to waive their redemption rights with
|
•
|
the founder shares are entitled to registration rights.
|
•
|
the net proceeds of this offering and the sale of the private placement warrants not held in the trust account, which will be approximately $1,000,000 in working capital after the payment of approximately $1,500,000 in expenses relating to this offering; and
|
•
|
any loans or additional investments from our sponsor, members of our management team or their affiliates or other third parties, although they are under no obligation to advance funds or invest in us, and provided that any such loans will not have any claim on the proceeds held in the trust account unless such proceeds are released to us upon completion of a business combination. Up to $1,500,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. These warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period.
|
•
|
conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and
|
•
|
file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about
|
•
|
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and
|
•
|
file proxy materials with the SEC.
|
•
|
repayment of up to an aggregate of $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses;
|
•
|
payment to an affiliate of our sponsor of $10,000 per month, for up to 24 months, for office space, utilities and secretarial and administrative support;
|
•
|
reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; and
|
•
|
repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period.
|
|
| |
MARCH 15, 2021
|
Balance Sheet Data:
|
| |
|
Working capital (deficiency)
|
| |
$ (21,212)
|
Total assets
|
| |
$45,250
|
Total liabilities
|
| |
$21,212
|
Stockholder’s equity
|
| |
$24,038
|
•
|
restrictions on the nature of our investments; and
|
•
|
restrictions on the issuance of securities, each of which may make it difficult for us to complete our business combination.
|
•
|
registration as an investment company;
|
•
|
adoption of a specific form of corporate structure; and
|
•
|
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.
|
•
|
we have a board that includes a majority of “independent directors,” as defined under the rules of Nasdaq;
|
•
|
we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and
|
•
|
director nominations be made, or recommended to the full board, by our independent directors or by a nominating committee of our board that is composed entirely of independent directors with a written charter or resolution addressing the committee’s purpose and responsibilities.
|
•
|
may significantly dilute the equity interest of investors in this offering;
|
•
|
may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;
|
•
|
could cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and
|
•
|
may adversely affect prevailing market prices for our units, Class A common stock and/or warrants.
|
•
|
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
|
•
|
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
|
•
|
our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
|
•
|
our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;
|
•
|
our inability to pay dividends on our common stock;
|
•
|
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;
|
•
|
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
|
•
|
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
|
•
|
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and
|
•
|
other disadvantages compared to our competitors who have less debt.
|
•
|
solely dependent upon the performance of a single business, property or asset; or
|
•
|
dependent upon the development or market acceptance of a single or limited number of products, processes or services.
|
•
|
higher costs and difficulties inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas markets;
|
•
|
rules and regulations regarding currency redemption;
|
•
|
complex corporate withholding taxes on individuals;
|
•
|
laws governing the manner in which future business combinations may be effected;
|
•
|
tariffs and trade barriers;
|
•
|
regulations related to customs and import/export matters;
|
•
|
longer payment cycles and challenges in collecting accounts receivable;
|
•
|
tax issues, such as tax law changes and variations in tax laws as compared to the United States;
|
•
|
currency fluctuations and exchange controls;
|
•
|
rates of inflation;
|
•
|
cultural and language differences;
|
•
|
employment regulations;
|
•
|
crime, strikes, riots, civil disturbances, terrorist attacks, natural disasters and wars;
|
•
|
deterioration of political relations with the United States; and
|
•
|
government appropriations of assets.
|
•
|
a limited availability of market quotations for our securities;
|
•
|
reduced liquidity for our securities;
|
•
|
a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
|
•
|
a limited amount of news and analyst coverage; and
|
•
|
a decreased ability to issue additional securities or obtain additional financing in the future.
|
•
|
the history and prospects of companies whose principal business is the acquisition of other companies;
|
•
|
prior offerings of those companies;
|
•
|
our prospects for acquiring an operating business;
|
•
|
a review of debt to equity ratios in leveraged transactions;
|
•
|
our capital structure;
|
•
|
an assessment of our management and their experience in identifying operating companies;
|
•
|
general conditions of the securities markets at the time of this offering; and
|
•
|
other factors as were deemed relevant.
|
•
|
our ability to select an appropriate target business or businesses;
|
•
|
our ability to complete our initial business combination;
|
•
|
our expectations around the performance of the prospective target business or businesses;
|
•
|
our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
|
•
|
our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;
|
•
|
our potential ability to obtain additional financing to complete our initial business combination;
|
•
|
our pool of prospective target businesses;
|
•
|
our ability to consummate an initial business combination due to the uncertainty resulting from the recent COVID-19 pandemic;
|
•
|
the ability of our officers and directors to generate a number of potential acquisition opportunities;
|
•
|
our public securities’ potential liquidity and trading;
|
•
|
the lack of a market for our securities;
|
•
|
the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;
|
•
|
the trust account not being subject to claims of third parties; or
|
•
|
our financial performance following this offering.
|
|
| |
Without
Over-Allotment
Option
|
| |
Over-Allotment
Option Fully
Exercised
|
Gross proceeds
|
| |
|
| |
|
Gross proceeds from units offered to public(1)
|
| |
$250,000,000
|
| |
$287,500,000
|
Gross proceeds from private placement warrants offered in the private
placement
|
| |
7,500,000
|
| |
8,250,000
|
Total gross proceeds
|
| |
$257,500,000
|
| |
$295,750,000
|
Offering expenses(2)
|
| |
|
| |
|
Underwriting commissions (2% of gross proceeds from units offered to public, excluding deferred portion)(3)
|
| |
$5,000,000
|
| |
$5,750,000
|
Legal fees and expenses
|
| |
350,000
|
| |
350,000
|
Accounting fees and expenses
|
| |
50,000
|
| |
50,000
|
SEC Expenses
|
| |
31,366
|
| |
31,366
|
FINRA Expenses
|
| |
43,625
|
| |
43,625
|
Nasdaq listing and filing fees
|
| |
75,000
|
| |
75,000
|
Director and Officer liability insurance premiums
|
| |
800,000
|
| |
800,000
|
Printing and engraving expenses
|
| |
50,000
|
| |
50,000
|
Miscellaneous
|
| |
100,009
|
| |
100,009
|
Total offering expenses (excluding underwriting commissions)
|
| |
$1,500,000
|
| |
$1,500,000
|
Proceeds after offering expenses
|
| |
$251,000,000
|
| |
$288,500,000
|
Held in trust account(3)
|
| |
$250,000,000
|
| |
$287,500,000
|
% of public offering size
|
| |
100%
|
| |
100%
|
Not held in trust account
|
| |
$1,000,000
|
| |
$1,00,000
|
|
| |
Amount
|
| |
of Total %
|
Legal, accounting, due diligence, travel, and other expenses in connection with any business combination(5)
|
| |
$500,000
|
| |
50.0%
|
Legal and accounting fees related to regulatory reporting obligations
|
| |
160,000
|
| |
16.0%
|
Nasdaq continued listing fees
|
| |
55,000
|
| |
5.5%
|
Reimbursement to Sponsor for office space, utilities and secretarial and administrative support (up to $10,000 per month for up to 24 months)
|
| |
240,000
|
| |
24.0%
|
Working capital to cover miscellaneous expenses
|
| |
45,000
|
| |
4.5%
|
Total
|
| |
$1,000,000
|
| |
100.0%
|
(1)
|
Includes gross proceeds from this offering of $250,000,000 (or $287,500,000 if the underwriters’ over-allotment option is exercised in full) as well as amounts payable to public stockholders who properly redeem their shares in connection with our successful completion of our initial business combination.
|
(2)
|
A portion of the offering expenses will be paid from the proceeds of loans from our sponsor of up to $300,000 as described in this prospectus. As of March 15, 2021, we had no borrowings under the promissory note with our sponsor. These amounts will be repaid upon completion of this offering out of the offering proceeds that has been allocated for the payment of offering expenses (other than underwriting commissions) and amounts not to be held in the trust account. In the event that offering expenses are less than set forth in this table, any such amounts will be used for post-closing working capital expenses. In the event that the offering expenses are more than as set forth in this table, we may fund such excess with funds not held in the trust account.
|
(3)
|
The underwriters have agreed to defer underwriting commissions equal to 3.5% of the gross proceeds of this offering. Upon completion of our initial business combination, $8,750,000, which constitutes the underwriters’ deferred commissions (or $10,062,500 if the underwriters’ over-allotment option is exercised in full) will be paid to the underwriters from the funds held in the trust account, and
|
(4)
|
The amount available outside of the trust account assumes that the underwriters’ over-allotment option is not exercised. These expenses are estimates only, and do not include interest which may be available to us from the trust account. Our actual expenditures for some or all of these items may differ from the estimates set forth herein. For example, we may incur greater legal and accounting expenses than our current estimates in connection with negotiating and structuring our business combination based upon the level of complexity of such business combination. In the event we identify a business combination target in a specific industry subject to specific regulations, we may incur additional expenses associated with legal due diligence and the engagement of special legal counsel. In addition, our staffing needs may vary and as a result, we may engage a number of consultants to assist with legal and financial due diligence. We do not anticipate any change in our intended use of proceeds, other than fluctuations among the current categories of allocated expenses, which fluctuations, to the extent they exceed current estimates for any specific category of expenses, would not be available for our expenses.
|
(5)
|
Includes estimated amounts that may also be used in connection with our business combination to fund a “no shop” provision and commitment fees for financing.
|
|
| |
Without
Over-Allotment
|
| |
With
Over-Allotment
|
Public offering price
|
| |
$10.00
|
| |
$10.00
|
Net tangible book value before this offering
|
| |
$[ ]
|
| |
$[ ]
|
Increase attributable to public stockholders and sale of the private placement warrants
|
| |
$[ ]
|
| |
$[ ]
|
Pro forma net tangible book value after this offering
|
| |
$[ ]
|
| |
$[ ]
|
Dilution to public stockholders
|
| |
$[ ]
|
| |
$[ ]
|
Percentage of dilution to public stockholders
|
| |
[ ]%
|
| |
[ ]%
|
|
| |
Shares Purchased
|
| |
Total Consideration
|
| |
Average
Price Per
Share
|
||||||
|
| |
Number
|
| |
Percentage
|
| |
Amount
|
| |
Percentage
|
| ||
Initial Stockholders(1)
|
| |
6,250,000
|
| |
20.0%
|
| |
$25,000
|
| |
0.01%
|
| |
$0.004
|
Public Stockholders
|
| |
25,000,000
|
| |
80.0%
|
| |
250,000,000
|
| |
99.99%
|
| |
$10.000
|
|
| |
31,250,000
|
| |
100.0%
|
| |
$250,025,000
|
| |
100.00%
|
| |
|
(1)
|
Assumes no exercise of the underwriters’ over-allotment option and the corresponding forfeiture of an aggregate of 937,500 shares of Class B common stock held by our sponsor.
|
|
| |
Without
Over-Allotment
|
| |
With
Over-Allotment
|
Net tangible book value (deficit) before this offering
|
| |
$[ ]
|
| |
$[ ]
|
Net proceeds from this offering and sale of the private placement warrants, net of expenses(1)
|
| |
[ ]
|
| |
[ ]
|
Offering costs excluded from the net tangible book value before this offering
|
| |
[ ]
|
| |
[ ]
|
Warrant Liability
|
| |
[ ]
|
| |
[ ]
|
Deferred underwriters’ commissions payable
|
| |
[ ]
|
| |
[ ]
|
Amount of Class A common stock subject to redemption to maintain net tangible assets of $5,000,001
|
| |
[ ]
|
| |
[ ]
|
Total
|
| |
$[ ]
|
| |
$[ ]
|
Shares of Class B common stock outstanding prior to this offering
|
| |
[ ]
|
| |
[ ]
|
Shares of Class B common stock forfeited if over-allotment is not exercised
|
| |
[ ]
|
| |
—
|
Shares of Class A common stock included in the units offered
|
| |
[ ]
|
| |
[ ]
|
Less: Shares of Class A common stocks subject to redemption to maintain net tangible assets of $5,000,001
|
| |
[ ]
|
| |
[ ]
|
Total
|
| |
[ ]
|
| |
[ ]
|
(1)
|
Expenses applied against gross proceeds include offering expenses of $1,500,000 and underwriting commissions of $5,000,000 (or $5,750,000 if the underwriters’ over-allotment option is exercised in full) (excluding deferred underwriting commissions). See “Use of Proceeds.”
|
|
| |
March 15, 2021
|
|||
|
| |
Actual
|
| |
As Adjusted(1)
|
Note payable to related party(2)
|
| |
$—
|
| |
$—
|
Deferred underwriting commissions
|
| |
—
|
| |
[ ]
|
Warrant liability(3)
|
| |
[ ]
|
| |
[ ]
|
Class A common stock subject to possible redemption, 0 and [ ] shares, actual and as adjusted, respectively(4)
|
| |
—
|
| |
[ ]
|
Preferred stock, $0.0001 par value, 1,000,000 shares authorized, actual and as adjusted; none issued or outstanding, actual and as adjusted
|
| |
—
|
| |
—
|
Class A common stock, $0.0001 par value, 500,000,000 shares authorized, actual and as adjusted; 0 and [ ] shares issued and outstanding (excluding 0 and [ ] shares subject to possible redemption), actual and as adjusted, respectively
|
| |
—
|
| |
[ ]
|
Class B common stock, $0.0001 par value, 50,000,000 shares authorized, actual and as adjusted; 7,187,500 and 6,250,000 shares issued and outstanding, actual and as adjusted, respectively(5)
|
| |
[ ]
|
| |
[ ]
|
Additional paid-in capital
|
| |
[ ]
|
| |
[ ]
|
Accumulated deficit
|
| |
[ ]
|
| |
[ ]
|
Total stockholders’ equity
|
| |
[ ]
|
| |
[ ]
|
Total capitalization
|
| |
$[ ]
|
| |
$[ ]
|
(1)
|
Assumes the over-allotment option has not been exercised and the resulting forfeiture of 937,500 founder shares held by our sponsor has occurred.
|
(2)
|
Our sponsor has agreed to loan us up to $300,000 to be used for a portion of the expenses of this offering. As of March 15, 2021, we had no borrowings under the promissory note with our sponsor.
|
(3)
|
We will account for the 20,000,000 warrants to be issued in connection with this offering (12,500,000 warrants included in the units and 7,500,000 private placement warrants, assuming the underwriters’ over-allotment option is not exercised) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability at its fair value. Such warrant classification is also subject to re-evaluation at each reporting period.
|
(4)
|
Upon the completion of our initial business combination, we will provide our stockholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, subject to the limitations described herein whereby our net tangible assets will be maintained at a minimum of $5,000,001 and any limitations (including, but not limited to, cash requirements) created by the terms of the proposed business combination.
|
(5)
|
Actual share amount is prior to any forfeiture of founder shares by our sponsor and as adjusted amount assumes no exercise of the underwriters’ over- allotment option.
|
•
|
may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti- dilution provisions in the Class B common stock resulted in the issuance of Class A shares on a greater than one-to-one basis upon conversion of the Class B common stock;
|
•
|
may subordinate the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;
|
•
|
could cause a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;
|
•
|
may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and
|
•
|
may adversely affect prevailing market prices for our Class A common stock and/or warrants.
|
•
|
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
|
•
|
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
|
•
|
our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
|
•
|
our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;
|
•
|
our inability to pay dividends on our common stock;
|
•
|
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;
|
•
|
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
|
•
|
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
|
•
|
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and
|
•
|
other purposes and other disadvantages compared to our competitors who have less debt.
|
•
|
staffing for financial, accounting and external reporting areas, including segregation of duties;
|
•
|
reconciliation of accounts;
|
•
|
proper recording of expenses and liabilities in the period to which they relate;
|
•
|
evidence of internal review and approval of accounting transactions;
|
•
|
documentation of processes, assumptions and conclusions underlying significant estimates; and
|
•
|
documentation of accounting policies and procedures.
|
•
|
Sourcing, structuring, acquiring, integrating and selling businesses in and adjacent to our target sectors;
|
•
|
Operating sophisticated business and non-profit organizations and executing complex transactions;
|
•
|
Identifying, recruiting and developing promising talent;
|
•
|
Accessing the capital markets and marketing organizations; and,
|
•
|
Advising companies and boards on diverse corporate matters, including but not limited to the integration of socially positive concerns into business operations for value creation.
|
•
|
Passion to fulfill our mission to develop as a successful public company using our Social-Forward criteria.
|
•
|
Compelling sourcing opportunities and strategic relationships, including our highly differentiated sourcing engine provided via our relationship with secondaries investment firm Auldbrass Partners, as well as the collective networks of our officers, directors, and advisory board members.
|
•
|
Extensive influence and reach through a broad network that spans a range of leaders in business, entertainment, government and philanthropy.
|
•
|
Successful track record of investing, transaction and capital markets experience that demonstrates a strong ability to source, select and execute.
|
•
|
Deep insights into and subject matter expertise in a target-rich universe that provides a large total addressable market.
|
•
|
Values-based leadership attractive to target businesses and with the ability to amplify and validate the efforts of a Social-Forward Company.
|
•
|
Either demonstrate or appreciate the value of supporting health and well-being, quality education, reducing economic inequality and promoting decent work in the United States.
|
•
|
Are motivated to fulfill our mission and be positioned as, or further developed as, a Social-Forward Company.
|
•
|
Are excited about working with our company to realize in parallel both shareholder and social value.
|
•
|
Are positioned to materially benefit from our officers’ and directors’ knowledge of the target industry and relationships.
|
•
|
Have strong management teams with a clear vision to either maintaining or, if an early-stage business, creating sustainable cash flows.
|
•
|
Are positioned to benefit from access to public capital markets and the merits of being a Social-Forward Company.
|
•
|
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and
|
•
|
cause us to depend on the marketing and sale of a single product or limited number of products or services.
|
•
|
we issue (other than in a public offering) shares of Class A common stock that will be equal to or in excess of 20% of the number of shares of our Class A common stock then outstanding;
|
•
|
any of our directors, officers or substantial stockholders (as defined by the Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of common stock could result in an increase in outstanding shares of common stock or voting power of 5% or more; or
|
•
|
the issuance or potential issuance of common stock will result in our undergoing a change of control.
|
•
|
the timing of the transaction, including in the event we determine stockholder approval would require additional time and there is either not enough time to seek stockholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company;
|
•
|
the expected cost of holding a stockholder vote;
|
•
|
the risk that the stockholders would fail to approve the proposed business combination;
|
•
|
other time and budget constraints of the company; and
|
•
|
additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to stockholders.
|
•
|
conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and
|
•
|
file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.
|
•
|
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and
|
•
|
file proxy materials with the SEC.
|
|
| |
Redemptions in Connection
with Our Initial Business
Combination
|
| |
Other Permitted
Purchases of Public
Shares by Us or Our
Affiliates
|
| |
Redemptions if We
Fail to Complete
an Initial Business
Combination
|
Calculation of redemption price
|
| |
Redemptions at the time of our initial business combination may be made pursuant to a tender offer or in connection with a stockholder vote. The redemption price will be the same whether we conduct redemptions pursuant to a tender offer or in connection with a stockholder vote. In either case, our public stockholders may redeem their public shares for cash equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination (which is initially anticipated to be $10.00 per public share), including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding public shares, subject to the limitation that no redemptions will take place, if all of the redemptions would cause our net tangible assets to be less than $5,000,001 upon consummation of our initial business combination and any limitations (including but not limited to cash requirements) agreed to in connection with the
|
| |
If we seek stockholder approval of our initial business combination, our sponsor, directors, officers or their affiliates may purchase shares in privately negotiated transactions or in the open market prior to or following completion of our initial business combination. There is no limit to the prices that our sponsor, directors, officers or their affiliates may pay in these transactions.
|
| |
If we are unable to completed our business combination within 24 months from the closing of this offering, we will redeem all public shares at a per-share price, payable in cash, equal to the aggregate amount, then on deposit in the trust account (which is initially anticipated to be $10.00 per public share including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares.
|
|
| |
Redemptions in Connection
with Our Initial Business
Combination
|
| |
Other Permitted
Purchases of Public
Shares by Us or Our
Affiliates
|
| |
Redemptions if We
Fail to Complete
an Initial Business
Combination
|
|
| |
negotiation of terms of a proposed business combination.
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
Impact to remaining stockholders
|
| |
The redemptions in connection with our initial business combination will reduce the book value per share for our remaining stockholders, who will bear the burden of the deferred underwriting commissions and withdrawals from interest earned on the trust account to pay our franchise and income taxes.
|
| |
If the permitted purchases described above are made there would be no impact to our remaining stockholders because the purchase price would not be paid by us.
|
| |
The redemption of our public shares if we fail to complete our business combination will reduce the book value per share for the shares held by our initial stockholders, who will be our only remaining stockholders after such redemptions.
|
|
| |
Terms of Our Offering
|
| |
Terms Under a Rule 419 Offering
|
Escrow of offering proceeds
|
| |
$250,000,000 of the net proceeds of this offering and the sale of the private placement warrants will be deposited into a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee.
|
| |
Approximately $212,625,000 of the offering proceeds would be deposited into either an escrow account with an insured depositary institution or in a separate bank account established by a broker-dealer in which the broker-dealer acts as trustee for persons having the beneficial interests in the account.
|
|
| |
|
| |
|
Investment of net proceeds
|
| |
$250,000,000 of the net offering proceeds and the sale of the private placement warrants held in trust will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.
|
| |
Proceeds could be invested only in specified securities such as a money market fund meeting conditions of the Investment Company Act or in securities that are direct obligations of, or obligations guaranteed as to principal or interest by, the United States.
|
|
| |
|
| |
|
|
| |
Terms of Our Offering
|
| |
Terms Under a Rule 419 Offering
|
Receipt of interest on escrowed funds
|
| |
Interest on proceeds from the trust account to be paid to stockholders is reduced by (i) any income or franchise taxes paid or payable and (ii) in the event of our liquidation for failure to complete our initial business combination within the allotted time, up to $100,000 of net interest that may be released to us should we have no or insufficient working capital to fund the costs and expenses of our dissolution and liquidation.
|
| |
Interest on funds in escrow account would be held for the sole benefit of investors, unless and only after the funds held in escrow were released to us in connection with our completion of a business combination.
|
|
| |
|
| |
|
Limitation on fair value or net assets of target business
|
| |
Our initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of our assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the initial business combination.
|
| |
The fair value or net assets of a target business must represent at least 80% of the maximum offering proceeds.
|
|
| |
|
| |
|
Trading of securities issued
|
| |
The units will begin trading on or promptly after the date of this prospectus. The Class A common stock and warrants comprising the units will begin separate trading on the 52nd day following the date of this prospectus unless Citigroup Global Markets Inc. informs us of its decision to allow earlier separate trading, subject to our having filed the Current Report on Form 8-K described below and having issued a press release announcing when such separate trading will begin. We will file the Current Report on Form 8-K promptly after the closing of this offering, which is anticipated to take place three business days from the date of this prospectus. If the over-allotment option is exercised following the initial filing of such Current Report on Form 8-K, an additional Current Report on Form 8-K will be filed to provide updated financial information to reflect the exercise of the over-allotment option.
|
| |
No trading of the units or the underlying Class A common stock and warrants would be permitted until the completion of a business combination. During this period, the securities would be held in the escrow or trust account.
|
|
| |
Terms of Our Offering
|
| |
Terms Under a Rule 419 Offering
|
Exercise of the warrants
|
| |
The warrants cannot be exercised until the later of 30 days after the completion of our initial business combination or twelve months from the closing of this offering.
|
| |
The warrants could be exercised prior to the completion of a business combination, but securities received and cash paid in connection with the exercise would be deposited in the escrow or trust account.
|
|
| |
|
| |
|
Election to remain an investor
|
| |
We will provide our public stockholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of the then outstanding public shares, upon the completion of our initial business combination, subject to the limitations described herein. We may not be required by law to hold a stockholder vote. If we are not required by law and do not otherwise decide to hold a stockholder vote, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC which will contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, we hold a stockholder vote, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the tender offer rules. If we seek stockholder approval, we will complete our initial business combination only if a majority of the outstanding shares of common stock voted are voted in favor of the business combination. Additionally, each public stockholder may elect to redeem their public shares irrespective of whether they vote for
|
| |
A prospectus containing information pertaining to the business combination required by the SEC would be sent to each investor. Each investor would be given the opportunity to notify the company in writing, within a period of no less than 20 business days and no more than 45 business days from the effective date of a post-effective amendment to the company’s registration statement, to decide if it elects to remain a stockholder of the company or require the return of its investment. If the company has not received the notification by the end of the 45th business day, funds and interest or dividends, if any, held in the trust or escrow account are automatically returned to the stockholder. Unless a sufficient number of investors elect to remain investors, all funds on deposit in the escrow account must be returned to all of the investors and none of the securities are issued.
|
|
| |
Terms of Our Offering
|
| |
Terms Under a Rule 419 Offering
|
|
| |
or against the proposed transaction. A quorum for such meeting will consist of the holders present in person or by proxy of shares of outstanding capital stock of the company representing a majority of the voting power of all outstanding shares of capital stock of the company entitled to vote at such meeting.
|
| |
|
|
| |
|
| |
|
Business combination deadline
|
| |
If we are unable to complete an initial business combination within 24 months from the closing of this offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
|
| |
If an acquisition has not been completed within 18 months after the effective date of the company’s registration statement, funds held in the trust or escrow account are returned to investors.
|
|
| |
|
| |
|
Release of funds
|
| |
Except for the withdrawal of interest income to pay our franchise and income taxes, the proceeds from this offering held in the trust account will not be released from the trust account until the earliest to occur of: (a) the completion of our initial
|
| |
The proceeds held in the escrow account are not released until the earlier of the completion of a business combination or the failure to effect a business combination within the allotted time.
|
|
| |
Terms of Our Offering
|
| |
Terms Under a Rule 419 Offering
|
|
| |
business combination, (b) the redemption of any public shares properly tendered in connection with a stockholder vote to amend our amended and restated certificate of incorporation (i) to modify the substance or timing of our obligation to provide holders of our Class A common stock the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or (ii) with respect to any other provisions relating to the rights of holders of our Class A common stock, and (c) the redemption of our public shares if we have not consummated our business combination within 24 months from the closing of this offering, subject to applicable law.
|
| |
|
Name
|
| |
Age
|
| |
Position
|
Westley Moore
|
| |
42
|
| |
Chairman
|
Carl Stanton
|
| |
52
|
| |
Chief Executive Officer
|
Ernest Lyles
|
| |
42
|
| |
Chief Financial Officer
|
Howard Sanders
|
| |
54
|
| |
Director
|
Troy Carter
|
| |
48
|
| |
Director Nominee
|
Jerri DeVard
|
| |
62
|
| |
Director Nominee
|
Dawanna Williams
|
| |
52
|
| |
Director Nominee
|
•
|
the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by us;
|
•
|
pre-approving all audit and permitted non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
|
•
|
reviewing and discussing with the independent registered public accounting firm all relationships they have with us in order to evaluate their continued independence;
|
•
|
setting clear hiring policies for employees or former employees of the independent registered public accounting firm;
|
•
|
setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
|
•
|
obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i) the independent registered public accounting firm’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the independent registered public accounting firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;
|
•
|
reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
|
•
|
reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
|
•
|
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Executive Officers’ compensation, evaluating our Executive Officers’ performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Executive Officers based on such evaluation;
|
•
|
reviewing and approving on an annual basis the compensation of all of our other officers;
|
•
|
reviewing on an annual basis our executive compensation policies and plans;
|
•
|
implementing and administering our incentive compensation equity-based remuneration plans;
|
•
|
assisting management in complying with our proxy statement and annual report disclosure requirements;
|
•
|
approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;
|
•
|
if required, producing a report on executive compensation to be included in our annual proxy statement; and
|
•
|
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
|
•
|
None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.
|
•
|
In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
|
•
|
Our initial stockholders have agreed (i) to waive their redemption rights with respect to any founder shares and public shares held by them in connection with the completion of our initial business combination and a stockholder vote to approve an amendment to our amended and restated certificate of incorporation (A) that would modify the substance or timing of our obligation to provide holders of shares of Class A common stock the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or (B) with respect to any other provision relating to the rights of holders of our Class A commons stock and (ii) to waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination within 24 months from the closing of this offering (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed time frame). If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private placement warrants held in the trust account will be used to fund the redemption of our public shares, and the private placement warrants will expire worthless. With certain limited exceptions, the founder shares will not be transferable, assignable by our sponsor until the earlier of: (A) one year after the completion of our initial business combination; or (B) subsequent to our initial business combination, (x) if the closing price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property. With certain limited exceptions, the private placement warrants and the Class A common stock underlying such warrants, will not be transferable, assignable or saleable by our sponsor or its permitted transferees until 30 days after the completion of our initial business combination. Since our sponsor and officers and directors may directly or indirectly own common stock and warrants following this offering, our officers and directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
|
•
|
Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.
|
•
|
Our sponsor, officers or directors may have a conflict of interest with respect to evaluating a business combination and financing arrangements as we may obtain loans from our sponsor or an affiliate of our sponsor or any of our officers or directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period.
|
•
|
the corporation could financially undertake the opportunity;
|
•
|
the opportunity is within the corporation’s line of business; and
|
•
|
it would not be fair to our company and its stockholders for the opportunity not to be brought to the attention of the corporation.
|
Individual
|
| |
Entity
|
| |
Entity’s Business
|
| |
Affiliation
|
Carl Stanton
|
| |
Westwood Estate Wines
|
| |
Food and Beverage
|
| |
Managing Partner
|
|
| |
cbGrowth Partners
|
| |
Investments
|
| |
Founder
|
Ernest Lyles
|
| |
The HiGro Group
|
| |
Private Equity
|
| |
Founder and Managing Partner
|
Westley Moore
|
| |
Robin Hood Foundation
|
| |
Charitable Organization
|
| |
Chief Executive Officer
|
Howard Sanders
|
| |
Auldbrass Partners L.P.
|
| |
Private Equity
|
| |
Founder and Managing Member
|
Troy Carter
|
| |
Q&A
|
| |
Technology and Multimedia
|
| |
Founder and Chief Executive Officer
|
|
| |
Aspen Institute
|
| |
Nonprofit Organization
|
| |
Executive Member on the Board of Trustees
|
Jerri DeVard
|
| |
Office Depot, Inc.
|
| |
Retail
|
| |
Executive Vice President, Chief Customer Officer
|
|
Under Armour Inc.
|
| |
Sports Equipment
Manufacturer
|
| |
Director
|
||
|
Cars.com
|
| |
Automotive
|
| |
Director
|
||
|
Roots Insurance
|
| |
Insurance
|
| |
Director
|
||
Dawanna Williams
|
| |
Dabar Development Partners
|
| |
Real Estate
|
| |
Managing Principal
|
•
|
each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;
|
•
|
each of our executive officers, directors and director nominees that beneficially owns shares of our common stock; and
|
•
|
all our executive officers, directors and director nominees as a group.
|
|
| |
Before Offering
|
| |
After Offering
|
||||||
Name and Address of Beneficial Owner(1)
|
| |
Number of
Shares
Beneficially
Owned(2)
|
| |
Approximate
Percentage of
Outstanding
Common Stock
|
| |
Number of
Shares
Beneficially
Owned(2)
|
| |
Approximate
Percentage of
Outstanding
Common Stock
|
Focus Impact Sponsor, LLC(3)
|
| |
7,187,500
|
| |
100.0%
|
| |
6,250,000
|
| |
20.0%
|
Westley Moore
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
Carl Stanton
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
Ernest Lyles
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
Howard Sanders
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
Troy Carter
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
Jerri DeVard
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
Dawanna Williams
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
| |
—(4)
|
All executive officers, directors and director nominees as a group (seven individuals)
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
*
|
Less than one percent.
|
(1)
|
Unless otherwise noted, the business address of each of the following entities or individuals is to 250 Park Avenue Ste 911, New York, NY, 10177.
|
(2)
|
Interests shown consist solely of founder shares, classified as shares of Class B common stock. Such shares are convertible into shares of Class A common stock on a one-for-one basis, subject to adjustment, as described in the section of this prospectus entitled “Description of Securities.”
|
(3)
|
Our sponsor is governed by a four-member board of managers composed of Carl Stanton, Ernest Lyles, Wes Moore and Howard Sanders. Each manager has one vote, and the approval of a majority of the managers is required to approve an action of our sponsor. Under the so-called “rule of three,” if voting and dispositive decisions regarding an entity’s securities are made by three or more individuals, and a voting and dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity’s securities. This is the situation with regard to our sponsor. Based upon the foregoing analysis, no individual manager of our sponsor exercises voting or dispositive control over any of the securities held by our sponsor, even those in which such manager directly holds a pecuniary interest. Accordingly, none of them will be deemed to have or share beneficial ownership of such shares.
|
(4)
|
Does not include any shares indirectly owned by this individual as a result of his membership interest in our sponsor.
|
•
|
repayment of up to an aggregate of $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses;
|
•
|
payment to an affiliate of our sponsor of $10,000 per month, for up to 24 months, for office space, utilities and secretarial and administrative support;
|
•
|
reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; and
|
•
|
repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender.
|
•
|
25,000,000 shares of our Class A common stock underlying the units being offered in this offering; and
|
•
|
6,250,000 shares of Class B common stock held by our initial stockholders.
|
•
|
in whole and not in part;
|
•
|
at a price of $0.01 per warrant;
|
•
|
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
|
•
|
if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Stockholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders.
|
•
|
in whole and not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of our Class A common stock (as defined below) except as otherwise described below;
|
•
|
if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Stockholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders; and
|
•
|
if the closing price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants — Public Stockholders’ Warrants— Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
|
•
|
if we are unable to complete our initial business combination within 24 months from the closing of this offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law;
|
•
|
prior to our initial business combination, we may not issue additional shares of capital stock that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote as a class with our public shares (a) on our initial business combination or on any other proposal presented to stockholders prior to or in connection with the completion of an initial business combination or (b) to approve an amendment to our amended and restated certificate of incorporation to (x) extend the time we have to consummate a business combination beyond 24 months from the closing of this offering or (y) amend the foregoing provisions;
|
•
|
although we do not intend to enter into a business combination with a target business that is affiliated with or related to Auldbrass Partners or our sponsor, officers, directors or members of our advisory board we are not prohibited from doing so. In the event we enter into such a transaction, a committee of independent and disinterested directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that such a business combination is fair to our company from a financial point of view;
|
•
|
if a stockholder vote on our initial business combination is not required by law and we do not decide to hold a stockholder vote for business or other legal reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act. Whether or not we maintain our registration under the Exchange Act or our listing on Nasdaq, we will provide our public stockholders with the opportunity to redeem their public shares by one of the two methods listed above;
|
•
|
our initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of our assets held in the trust account excluding the deferred underwriting commissions and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the initial business combination;
|
•
|
if our stockholders approve an amendment to our amended and restated certificate of incorporation that would affect the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our business combination within 24 months from the closing of this offering or with respect to any other provisions relating to the rights of holders of our Class A common stock, we will provide our public stockholders with the opportunity to redeem all or a portion of their shares of Class A common stock upon such approval at a per- share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding public shares; and
|
•
|
we will not effectuate our initial business combination with another blank check company or a similar company with nominal operations.
|
•
|
prior to such time, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;
|
•
|
upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding certain shares; or
|
•
|
at or subsequent to that time, the business combination is approved by our board of directors and by the affirmative vote of holders of at least 662⁄3% of the outstanding voting stock that is not owned by the interested stockholder.
|
•
|
1% of the total number of shares of common stock then outstanding, which will equal 312,500 shares immediately after this offering (or 359,375 if the underwriters exercise their over-allotment option in full); or
|
•
|
the average weekly reported trading volume of the common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.
|
•
|
the issuer of the securities that was formerly a shell company has ceased to be a shell company;
|
•
|
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
|
•
|
the issuer of the securities has filed all Exchange Act reports and materials required to be filed, as applicable, during the preceding twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and
|
•
|
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.
|
•
|
financial institutions;
|
•
|
insurance companies;
|
•
|
dealers or traders subject to a mark-to-market method of accounting with respect to the securities;
|
•
|
regulated investment companies and real estate investment trusts;
|
•
|
persons holding the securities as part of a “straddle,” hedge, integrated transaction or similar transaction;
|
•
|
U.S. holders (as defined below) whose functional currency is not the U.S. dollar;
|
•
|
governments or agencies and their controlled entities or instrumentalities;
|
•
|
persons subject to anti-inversion rules;
|
•
|
persons required to accelerate the recognition of any item of gross income as a result of Section 451(b) of the Code;
|
•
|
former citizens or residents of the United States;
|
•
|
persons that actually or constructively own five percent or more of the total combined voting power or value of our shares;
|
•
|
partnerships or other pass-through entities for U.S. federal income tax purposes and any beneficial owners of such entities; and
|
•
|
tax-exempt entities.
|
•
|
an individual who is a citizen or resident of the United States;
|
•
|
a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or under the laws of the United States, any state thereof or the District of Columbia;
|
•
|
an estate, the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or
|
•
|
a trust, if (i) a court within the United States is able to exercise primary jurisdiction over its administration and one or more U.S. persons has the authority to control all of its substantial decisions, or (ii) a valid election is in place under applicable U.S. Treasury regulations to treat such trust as a domestic trust.
|
•
|
the gain is effectively connected with the conduct of a trade or business by the Non-U.S. holder within the United States (and, under certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the Non-U.S. holder);
|
•
|
the Non-U.S. holder is an individual present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or
|
•
|
we are or have been a “U.S. real property holding corporation” for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the Non-U.S. holder held our Class A common stock, and, in the case where shares of our Class A common stock are regularly traded on an established securities market, the Non-U.S. holder has owned, directly or constructively (including through ownership of warrants) more than 5% of our Class A common stock at any time within the shorter of the five-year period preceding the disposition or such Non-U.S. holder’s holding period for the shares of our Class A common stock. There can be no assurance that our Class A common stock will be treated as regularly traded on an established securities market for this purpose.
|
Underwriter
|
| |
Number of
Units
|
Citigroup Global Markets Inc.
|
| |
|
Goldman Sachs & Co. LLC
|
| |
|
CastleOak Securities, L.P.
|
| |
|
Siebert Williams Shank & Co., LLC
|
| |
|
Total
|
| |
25,000,000
|
|
| |
Paid By Us
|
|||
|
| |
No Exercise
|
| |
Full Exercise
|
Per Unit(1)
|
| |
$0.55
|
| |
$0.55
|
Total(1)
|
| |
$13,750,000
|
| |
$15,812,500
|
(1)
|
Includes $0.35 per unit, or $8,750,000 in the aggregate (or $10,062,500 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable to the underwriters for deferred underwriting commissions to be placed in a trust account at J.P. Morgan Chase Bank, N.A. with Continental Stock Transfer & Trust Company acting as trustee, as described herein, and released to the underwriters only upon the consummation of an initial business combination.
|
•
|
Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum.
|
•
|
Over-allotment involves sales by the underwriters of units in excess of the number of units the underwriters are obligated to purchase, which creates a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered short position, the number of units over-allotted by the underwriters is not greater than the number of units that they may purchase in the over-allotment option. In a naked short position, the number of units involved is greater than the number of units in the over-allotment option. The underwriters may close out any covered short position by either exercising their over-allotment option and/or purchasing units in the open market.
|
•
|
Syndicate covering transactions involve purchases of the units in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of units to close out the short position, the underwriters will consider, among other things, the price of units available for purchase in the open market as compared to the price at which they may purchase units through the over-allotment option. If the underwriters sell more units than could be covered by the over-allotment option, resulting in a naked short position, the position can only be closed out by buying units in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the units in the open market after pricing of this offering that could adversely affect investors who purchase in this offering.
|
(a)
|
to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
|
(b)
|
to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the representative; or
|
(c)
|
in any other circumstances falling within Article 1(4) of the Prospectus Regulation,
|
(a)
|
to any legal entity which is a qualified investor as defined in Article 2 of the UK Prospectus Regulation;
|
(b)
|
to fewer than 150 natural or legal persons (other than qualified investors as defined in Article 2 of the UK Prospectus Regulation in the UK subject to obtaining the prior consent of the representatives of the underwriters for any such offer; or
|
(c)
|
in any other circumstances falling within section 86 of the UK's Financial Services and Markets Act 2000, as amended (the “FSMA”),
|
•
|
a “sophisticated investor” under section 708(8)(a) or (b) of the Corporations Act;
|
•
|
a “sophisticated investor” under section 708(8)(c) or (d) of the Corporations Act and that you have provided an accountant’s certificate to the Company which complies with the requirements of section 708(8)(c)(i) or (ii) of the Corporations Act and related regulations before the offer has been made;
|
•
|
a person associated with the Company under Section 708(12) of the Corporations Act; or
|
•
|
a “professional investor” within the meaning of section 708(11)(a) or (b) of the Corporations Act.
|
•
|
released, issued, distributed or caused to be released, issued or distributed to the public in France; or
|
•
|
used in connection with any offer for subscription or sale of the units to the public in France. Such offers, sales and distributions will be made in France only:
|
•
|
to qualified investors (investisseurs qualifiés) and/or to a restricted circle of investors (cercle restreint d’investisseurs), in each case investing for their own account, all as defined in, and in accordance with, Article L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the French Code monétaire et financier;
|
•
|
to investment services providers authorized to engage in portfolio management on behalf of third parties; or
|
•
|
in a transaction that, in accordance with article L.411-2-II-1° -or-2°-or 3° of the French Code monétaire et financier and article 211-2 of the General Regulations (Règlement Général) of the Autorité des Marchés Financiers, does not constitute a public offer (appel public à l’épargne).
|
•
|
the purchaser is entitled under applicable provincial securities laws to purchase the units without the benefit of a prospectus qualified under those securities laws as it is an “accredited investor” as defined under National Instrument 45-106 - Prospectus Exemptions;
|
•
|
the purchaser is a “permitted client” as defined in National Instrument 31-103 - Registration Requirements, Exemptions and Ongoing Registrant Obligations;
|
•
|
where required by law, the purchaser is purchasing as principal and not as agent; and
|
•
|
the purchaser has reviewed the text above under Resale Restrictions.
|
Assets
|
| |
|
Deferred offering costs
|
| |
$45,250
|
Total Assets
|
| |
$45,250
|
|
| |
|
Liabilities and Stockholder’s Equity
|
| |
|
Current liabilities:
|
| |
|
Accrued offering costs and expenses
|
| |
$21,212
|
Total current liabilities
|
| |
$21,212
|
|
| |
|
Commitments and Contingencies (See Note 6)
|
| |
|
|
| |
|
Stockholder’s Equity:
|
| |
|
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
|
| |
$—
|
Class A common stock, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding
|
| |
—
|
Class B common stock, $0.0001 par value; 50,000,000 shares authorized; 7,187,500 shares issued and outstanding(1)
|
| |
719
|
Additional paid-in capital
|
| |
24,281
|
Accumulated deficit
|
| |
(962)
|
Total Stockholder’s Equity
|
| |
24,038
|
Total Liabilities and Stockholder’s Equity
|
| |
$45,250
|
(1)
|
Includes up to 937,500 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).
|
Formation costs
|
| |
$962
|
Net loss
|
| |
$(962)
|
|
| |
|
Basic and diluted weighted average shares outstanding(1)
|
| |
6,250,000
|
|
| |
|
Basic and diluted net loss per common stock
|
| |
$(0.00)
|
(1)
|
Excludes an aggregate of up to 937,500 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).
|
|
| |
Class B
common stock
|
| |
Additional
Paid-in
Capital
|
| |
Accumulated
Deficit
|
| |
Total
Stockholder’s
Equity
|
|||
|
| |
Shares(1)
|
| |
Amount
|
| ||||||||
Balance as of February 23, 2021(inception)
|
| |
—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
Class B common stock issued to Sponsor
|
| |
7,187,500
|
| |
719
|
| |
24,281
|
| |
—
|
| |
25,000
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(962)
|
| |
(962)
|
Balance as of March 15, 2021
|
| |
7,187,500
|
| |
$719
|
| |
$24,281
|
| |
$(962)
|
| |
$24,038
|
(1)
|
Includes up to 937,500 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).
|
Cash Flows from Operating Activities:
|
| |
|
Net loss
|
| |
$(962)
|
Accrued offering costs and expenses
|
| |
962
|
Net cash used in operating activities
|
| |
—
|
|
| |
|
Net change in cash
|
| |
—
|
|
| |
|
Cash, February 23, 2021(inception)
|
| |
—
|
Cash, end of the period
|
| |
$—
|
|
| |
|
Supplemental disclosure of cash flow information:
|
| |
|
Deferred offering costs included in accrued offering costs and expenses
|
| |
$20,250
|
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock
|
| |
$25,000
|
•
|
in whole and not in part;
|
•
|
at a price of $0.01 per warrant;
|
•
|
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
|
•
|
if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.
|
•
|
in whole and not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption;
|
•
|
if, and only if, the closing price of the Company’s Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and
|
•
|
if the closing price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
|
Citigroup
|
| |
Goldman Sachs & Co. LLC
|
CastleOak Securities, L.P.
|
| |
Siebert Williams Shank
|
Item 13.
|
Other Expenses of Issuance and Distribution.
|
SEC expenses
|
| |
$31,366
|
FINRA expenses
|
| |
43,625
|
Accounting fees and expenses
|
| |
50,000
|
Printing and engraving expenses
|
| |
50,000
|
Legal fees and expenses
|
| |
350,000
|
Nasdaq listing and filing fees
|
| |
75,000
|
Director & Officers liability insurance premiums(1)
|
| |
800,000
|
Miscellaneous
|
| |
100,009
|
Total
|
| |
$ 1,500,000
|
(1)
|
This amount represents the approximate amount of annual director and officer liability insurance premiums the registrant anticipates paying following the completion of its initial public offering and until it completes a business combination.
|
Item 14.
|
Indemnification of Directors and Officers.
|
Item 15.
|
Recent Sales of Unregistered Securities.
|
Item 16.
|
Exhibits and Financial Statement Schedules.
|
Item 17.
|
Undertakings.
|
(1)
|
For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
|
(2)
|
For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
Exhibit No.
|
| |
Description
|
1.1
|
| |
Form of Underwriting Agreement.*
|
3.1
|
| |
Certificate of Incorporation.*
|
3.1
|
| |
Form of Amended and Restated Certificate of Incorporation.*
|
3.2
|
| |
Form of Amended and Restated Bylaws.*
|
4.1
|
| |
Specimen Unit Certificate.*
|
4.2
|
| |
Specimen Class A Common Stock Certificate.*
|
4.3
|
| |
Specimen Warrant Certificate.*
|
4.4
|
| |
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.*
|
5.1
|
| |
Opinion of Kirkland & Ellis LLP.*
|
10.1
|
| |
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.*
|
10.2
|
| |
Form of Registration and Stockholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto.*
|
10.3
|
| |
Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor.*
|
10.4
|
| |
Form of Indemnity Agreement.*
|
10.5
|
| |
Form of Administrative Services Agreement between the Registrant and the Sponsor.*
|
10.6
|
| |
Promissory Note, dated as of March 15, 2021, between the Registrant and the Sponsor.*
|
10.7
|
| |
Securities Subscription Agreement, dated March 15, 2021, between the Registrant and the Sponsor.*
|
10.8
|
| |
Form of Letter Agreement between the Registrant, the Sponsor and each director and executive officer of the Registrant.*
|
| |
Consent of Marcum LLP.
|
|
23.2
|
| |
Consent of Kirkland & Ellis LLP (included on Exhibit 5.1).*
|
24
|
| |
Power of Attorney (included on signature page to the initial filing of this Registration Statement).*
|
| |
Consent of Troy Carter.
|
|
| |
Consent of Jerri DeVard.
|
|
| |
Consent of Dawanna Williams.
|
*
|
To be filed by amendment.
|
|
| |
Focus Impact Acquisition Corp.
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Carl Stanton
|
|
| |
Name:
|
| |
Carl Stanton
|
|
| |
Title:
|
| |
Chief Executive Officer
|
Name
|
| |
Position
|
| |
Date
|
|
| |
|
| |
|
/s/ Westley Moore
|
| |
Chairman
|
| |
April 22, 2021
|
Westley Moore
|
| |
|
| |
|
|
| |
|
| |
|
/s/ Carl Stanton
|
| |
Chief Executive Officer
(Principal Executive Officer)
|
| |
April 22, 2021
|
Carl Stanton
|
| |
|
|||
|
| |
|
| |
|
/s/ Ernest Lyles
|
| |
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
| |
April 22, 2021
|
Ernest Lyles
|
| |
|
|||
|
| |
|
| |
|
/s/ Howard Sanders
|
| |
Director
|
| |
April 22, 2021
|
Howard Sanders
|
| |
|
| |
|
By:
|
/s/ Troy Carter
|
|
Name:
|
Troy Carter
|
By:
|
/s/ Jerri DeVard
|
|
Name:
|
Jerri DeVard
|
By:
|
/s/ Dawanna Williams
|
|
Name:
|
Dawanna Williams
|